arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

download Export Data

AVAI BIO, INC.

AVAI

— Price unavailable

30 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

AVAI BIO, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 7.2% ↘

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-487.59K

↑ +7.8% —

FCF / Share Free cash flow per share

$-0.00

↑ +6.8% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
EPS Growth YoY (%)	—	—	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	-0.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	—	7.8% Fair → Fair Stable Year-over-year change in net income	7.8% Fair ↑ Fair Improving Year-over-year change in net income	7.8% Fair ↑ Fair Improving Year-over-year change in net income	N/M	-28.5% Weak → Weak Stable Year-over-year change in net income	-28.5% Weak Weak Year-over-year change in net income	-28.5% Weak Weak Year-over-year change in net income	—	N/M	N/M	N/M	—	N/M	685.4% Excellent ↑ Excellent Improving Year-over-year change in net income	675.9% Excellent Excellent Year-over-year change in net income	—	-4003.9% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	64.8% Excellent Excellent Year-over-year change in net income	—	-137.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	-1494.4% Weak Weak Year-over-year change in free cash flow	—	—	—	89.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
FCF / Net Income (x)	—	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.71x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	-0.14x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	-0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	8.15x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.40x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
Return on Invested Capital (%)	7.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	15.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	15.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	19.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	138.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	213.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	19.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-199.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	465.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	3.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-320.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	42.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-44.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-320.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-195.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-335.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1222.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-1227.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-21.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	81.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	23.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	45.5% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	-1.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	36.3% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—	—	-87.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	—	17.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-6%)	21.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	24.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+32%)	-29.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	24.8% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	29.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+58%)	25.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+37%)	20.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	—	—	—	—	—	—	—	—	124.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+575%)	68.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+272%)	—	-35.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	7.7% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-59%)	34.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+85%)	—	58.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+214%)	—	—	211.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1041%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
Net Debt (USD)	$-23.14K	$-50.40K	$-92.00K	$-10.06K	$-81.05K	$-3.07K	$-1.77K	$-444.00	$-281.00	—	—	—	$-33.29K	$-4.58K	—	$-18.99K	$-60.36K	$-29.51K	$-16.67K	$-12.82K	$-27.30K	$-498.00	$-701.00	—	$-102.00	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
Basic EPS, GAAP (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.01	$0.00	$0.01	$-0.01	$-0.01	$0.00	$0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-0.00	$-0.00	$-0.00	—	—	—	$-0.00	—	$-0.01	$-0.01	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.02	$-0.02	$-0.02	$-0.01	$-0.01	$-0.02	$-0.01	$-0.02	$-0.01	—	—	—	$-0.02	—	$-0.00	$0.00	$-0.01	$-0.01	$0.00	$0.00	$-0.04	$-0.03	$-0.02	—	$-0.01	—	—	$-0.00	$0.00	$0.00
Tangible Book Value per Share (USD)	$-0.02	$-0.02	$-0.02	$-0.02	$-0.01	$-0.02	$-0.02	$-0.02	$-0.01	—	—	—	$-0.02	—	$-0.00	$0.00	$-0.01	$-0.02	$-0.00	$-0.01	$-0.04	$-0.06	$-0.04	—	$-0.01	—	—	$-0.00	$0.00	$0.00
Basic Weighted Avg Shares (shares)	—	138.03M	137.62M	137.46M	—	137.00M	123.60M	115.83M	—	74.84M	74.27M	57.65M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
Working Capital (USD)	$-3.30M	$-2.91M	$-2.42M	$-2.12M	$-1.70M	$-2.28M	$-1.98M	$-2.27M	$-1.67M	—	—	—	$-529.35K	$-552.67K	$-231.73K	$-112.98K	$-523.39K	$-584.03K	$-151.07K	$-243.06K	$-309.29K	$-290.24K	—	—	$-5.06K	—	—	$-2.94K	$641.00	$3.26K
Total Equity (USD)	$-2.82M	$-2.79M	$-2.30M	$-1.99M	$-1.56M	$-2.14M	$-1.81M	$-2.08M	$-1.47M	—	—	—	$-405.56K	—	$-66.02K	$67.26K	$-327.41K	$-334.12K	$73.23K	$13.39K	$-37.69K	$-132.66K	$-122.49K	—	$-49.61K	—	—	$-2.94K	$0.00	$3.26K

📋 What is driving earnings? 3 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2022 10-K ↗	Q3 FY2023 Dec 31, 2021 10-Q ↗	Q2 FY2023 Sep 30, 2021 10-Q ↗	Q1 FY2023 Jun 30, 2021 10-Q ↗	Q4 FY2022 Mar 31, 2021 10-K ↗	Q3 FY2022 Dec 31, 2020 10-Q ↗	Q2 FY2022 Sep 30, 2020 10-Q ↗	Q1 FY2022 Jun 30, 2020 10-Q ↗	Q4 FY2021 May 31, 2020 10-K ↗	Q3 FY2021 Dec 31, 2019 10-Q ↗	Q2 FY2021 Sep 30, 2019 10-Q ↗	Q1 FY2021 Jun 30, 2019 10-Q ↗	Q4 FY2020 Mar 31, 2019 10-K ↗	Q3 FY2020 Mar 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2018 10-Q ↗	Q1 FY2020 Jun 30, 2018 10-Q ↗	Q4 FY2019 Mar 31, 2018 10-K ↗	Q1 FY2019 Mar 31, 2018 10-Q ↗
Depreciation Expense (USD)	$6.52K	$6.52K	$6.52K	$6.52K	$15.77K	—	$0.00	$19.52K	$47.27K	$10.27K	$10.32K	$9.10K	—	—	—	—	—	$14.38K	$14.26K	$11.57K	—	—	—	$2.17K	$2.17K	$2.17K	—	—	—	—
Net Income, GAAP (USD)	—	$-487.59K	$-487.59K	$-487.59K	$464.07K	$-528.84K	$-528.84K	$-528.84K	$-303.43K	$-411.52K	$-411.52K	$-411.52K	—	$396.33K	$396.33K	$396.33K	—	$-417.16K	$50.46K	$51.08K	$13.45K	$-10.16K	$-41.89K	$-14.70K	$-28.84K	$-28.84K	—	$-6.20K	—	—
Operating Cash Flow (USD)	$-50.83K	$-347.13K	$-371.55K	$-240.34K	$-187.50K	—	—	$-12.70K	$-136.52K	$-705.67K	$-420.40K	$-59.73K	$515.97K	—	—	$-56.85K	$-45.16K	—	—	$-24.00K	$109.58K	—	—	$-5.88K	$-2.27K	$-8.48K	$-67.82K	$-5.60K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

AVAI BIO, INC.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AVAI with peers